Sonia MARTIAL

Dr. Sonia MARTIAL

Normal and Pathological Angiogenesis, Institute of Research on Cancer and Aging in Nice, Nice, Provence-Alpes-Côte d’Azur, France
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1995 in Journal of Biological Chemistry
Verified
Journal Article
Open access
BOBernadette Olivès
Bernadette Olivès
MMMarie-Geneviève Mattei
Marie-Geneviève Mattei
MHMartine Huet
Martine Huet
PNPhilippe Neau
Philippe Neau
SMSonia MARTIAL
Sonia MARTIAL
PBPascal Bailly
Pascal Bailly
The gene encoding the urea transporter of human erythrocytes (HUT11 clone) has been cloned recently (Olives, B., Neau, P., Bailly, P., Hediger, M. A., Rousselet, G., Cartron, J. P., and Ripoche, P. (1994) J. Biol. Chem. 269, 31649-31652). Now, this gene has been assigned to chromosome 18q12-q21 by in situ hybridization, as also found for the Kidd (Jk) blood group locus. In coupled transcription-translation assays, the HUT11 cDNA directed the synthesis of a 36-kDa protein which was immunoprecipitated by a human anti-Jk3 antibody produced by immunized Jk(a-b-) donors whose red cells lack Kidd antigens. The anti-Jk3 antibody also immunoprecipitated a protein material of 46-60 kDa from all red cell membranes, except those from Jk(a-b-) cells. After N-glycanase digestion the 46-60-kDa component was reduced to 36 kDa. A rabbit antibody raised against the predicted NH2-terminal amino-acids of the HUT11 protein reacted on immunoblots with a 46-60-kDa component present in all human erythrocytes except those from Jk(a-b-) individuals. Jk(a-b-) red cells lack the Kidd/urea transport protein and have a selective defect of the urea transport capacity, but a normal water permeability and aquaporin-associated Colton blood group antigens. These findings indicate that the erythrocyte urea transporter is encoded by the Kidd locus and may have implications for the biology of urea transporters and their tissue-specific regulation.

1 September 1995 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CSC P Smith
C P Smith
WLW S Lee
W S Lee
SMSonia MARTIAL
Sonia MARTIAL
MKM A Knepper
M A Knepper
GYG You
G You
MHMatthias A. Hediger
Matthias A. Hediger
In mammals, urea is the predominant end-product of nitrogen metabolism and plays a central role in the urinary-concentrating mechanism. Urea accumulation in the renal medulla is critical to the ability of the kidney to concentrate urine to an osmolality greater than systemic plasma. Regulation of urea excretion and accumulation in the renal medulla depends on the functional state of specialized phloretin-sensitive urea transporters. To study these transporters and their regulation of expression we isolated a cDNA which encodes the rat homologue (rUT2) of rabbit UT2 (You, G., C.P. Smith, Y. Kanai, W.-S. Lee, M. Stelzner, and M.A. Hediger, et al. Nature (Lond.). 1993. 365:844-847). Rat UT2 has 88% amino acid sequence identity to rabbit UT2 and 64% identity to the recently cloned human erythrocyte urea transporter, HUT11 (Olives, B., P. Neav, P. Bailly, M.A. Hediger, G. Rousselet, J.P. Cartron, and P. Ripoch J. Biol. Chem. 1994. 269:31649-31652). Analysis of rat kidney mRNA revealed two transcripts of size 2.9 and 4.0 kb which had spatially distinct distributions. Northern analysis and in situ hybridization showed that the 4.0-kb transcript was primarily responsive to changes in the protein content of the diet whereas the 2.9-kb transcript was responsive to changes in the hydration state of the animal. These studies reveal that the expression levels of the two rUT2 transcripts are modulated by different pathways to allow fluid and nitrogen balance to be regulated independently. Our data provide important insights into the regulation of the renal urea transporter UT2 and provide a basis on which to refine our understanding of the urinary concentrating mechanism and its regulation.

20 May 1996 in FEBS Letters
Verified
Journal Article
Closed access
BOBernadette Olivès
Bernadette Olivès
SMSonia MARTIAL
Sonia MARTIAL
MMMarie-Geneviève Mattei
Marie-Geneviève Mattei
GMGiorgio Matassi
Giorgio Matassi
GRGermain Rousselet
Germain Rousselet
PBPascal Bailly
Pascal Bailly

1 November 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
OGOleksandr Grytsai
Oleksandr Grytsai
OVOksana Valiashko
Oksana Valiashko
MPManon Penco-Campillo
Manon Penco-Campillo
MDMaeva Dufies
Maeva Dufies
AHAnais Hagege
Anais Hagege
RBRachid Benhida
Rachid Benhida

1 August 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DCDavid Crottès
David Crottès
SMSonia MARTIAL
Sonia MARTIAL
RRRaphaël Rapetti-Mauss
Raphaël Rapetti-Mauss
Didier PisaniDidier Pisani
Didier Pisani
CLCéline Loriol
Céline Loriol
OSOlivier Soriani
Olivier Soriani
Sig1R (Sigma-1receptor) is a 25-kDa protein structurally unrelated to other mammalian proteins. Sig1R is present in brain, liver, and heart and is overexpressed in cancer cells. Studies using exogenous sigma ligands have shown that Sig1R interacts with a variety of ion channels, but its intrinsic function and mechanism of action remain unclear. The human ether-à-gogo related gene (hERG) encodes a cardiac channel that is also abnormally expressed in many primary human cancers, potentiating tumor progression through the modulation of extracellular matrix adhesive interactions. We show herein that sigma ligands inhibit hERG current density and cell adhesion to fibronectin in K562 myeloid leukemia cells. Heterologous expression in Xenopus oocytes demonstrates that Sig1R potentiates hERG current by stimulating channel subunit biosynthesis. Silencing Sig1R in leukemic K562 cells depresses hERG current density and cell adhesion to fibronectin by reducing hERG membrane expression. In K562 cells, Sig1R silencing does not modify hERG mRNA contents but reduces hERG mature form densities. In HEK cells expressing hERG and Sig1R, both proteins co-immunoprecipitate, demonstrating a physical association. Finally, Sig1R expression enhances both channel protein maturation and stability. Altogether, these results demonstrate for the first time that Sig1R controls ion channel expression through the regulation of subunit trafficking activity.

31 January 2016 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DCDavid Crottès
David Crottès
RRRaphael Rapetti-Mauss
Raphael Rapetti-Mauss
FAFrancisca Alcaraz-Pérez
Francisca Alcaraz-Pérez
MTMélanie Tichet
Mélanie Tichet
GGGiuseppina Gariano
Giuseppina Gariano
OSOlivier Soriani
Olivier Soriani
The sigma 1 receptor (Sig1R) is a stress-activated chaperone that regulates ion channels and is associated with pathologic conditions, such as stroke, neurodegenerative diseases, and addiction. Aberrant expression levels of ion channels and Sig1R have been detected in tumors and cancer cells, such as myeloid leukemia and colorectal cancer, but the link between ion channel regulation and Sig1R overexpression during malignancy has not been established. In this study, we found that Sig1R dynamically controls the membrane expression of the human voltage-dependent K+ channel human ether-à-go-go-related gene (hERG) in myeloid leukemia and colorectal cancer cell lines. Sig1R promoted the formation of hERG/β1-integrin signaling complexes upon extracellular matrix stimulation, triggering the activation of the PI3K/AKT pathway. Consequently, the presence of Sig1R in cancer cells increased motility and VEGF secretion. In vivo, Sig1R expression enhanced the aggressiveness of tumor cells by potentiating invasion and angiogenesis, leading to poor survival. Collectively, our findings highlight a novel function for Sig1R in mediating cross-talk between cancer cells and their microenvironment, thus driving oncogenesis by shaping cellular electrical activity in response to extracellular signals. Given the involvement of ion channels in promoting several hallmarks of cancer, our study also offers a potential strategy to therapeutically target ion channel function through Sig1R inhibition. Cancer Res; 76(3); 607–18. ©2015 AACR.